Practical guidance for mismatch repair-deficiency testing in endometrial cancer by Stelloo, E, Jansen, A, Osse, E, Nout, R, Creutzberg, C, Church, D, Morreau, H, Smit, V, van Wezel, T, Bosse, T

Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues by Van Gool, I, Rayner, E, Osse, E, Nout, R, Creutzberg, C, Tomlinson, I, Church, D, Smit, V, de Wind, N, Bosse, T, Drost, M

Interpretation of somatic POLE mutations in endometrial carcinoma by León-Castillo, A, Britton, H, McConechy, MK, McAlpine, JN, Nout, R, Kommoss, S, Brucker, SY, Carlson, JW, Epstein, E, Rau, TT, Bosse, T, Church, DN, Gilks, CB

A multidisciplinary approach to giant cell tumors of tendon sheath and synovium--a critical appraisal of literature and treatment proposal. by van der Heijden, L, Gibbons, C, Hassan, A, Kroep, JR, Gelderblom, H, van Rijswijk, C, Nout, R, Bradley, K, Athanasou, N, Dijkstra, P, Hogendoorn, P, van de Sande, MA

POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer by Klenerman, P, Church, D, Tomlinson, I, van Gool, I, Eggink, F, Freeman-Mills, L, Stelloo, E, Marchi, E, de Bruyn, M, Palles, C, Nout, R, de Kroon, C, Osse, E, Creutzberg, C, Smit, V, Nijman, H, Bosse, T

Frequent homologous recombination deficiency in high-grade endometrial carcinomas by Jonge, D, Auguste, A, Van Wijk, L, Schouten, P, Meijers, M, Ter Haar, N, Smit, V, Nout, R, Glaire, M, Church, D, Vrieling, H, Job, B, Boursin, Y, De Kroon, C, Rouleau, E, Leary, A, Vreeswijk, M, Bosse, T

Clinicopathological and molecular characterisation of ‘multiple-classifier’ endometrial carcinomas by León-Castillo, A, Gilvazquez, E, Nout, R, Smit, VTHBM, McAlpine, JN, McConechy, M, Kommoss, S, Brucker, SY, Carlson, JW, Epstein, E, Rau, TT, Soslow, RA, Ganesan, R, Matias-Guiu, X, Oliva, E, Harrison, BT, Church, DN, Gilks, CB, Bosse, T